This review presents important information about the current state of the art for vaccine immunotherapy of prostate cancer. It includes important preclinical research for each of the important ...

May 19 -- SUNDAY, May 18 (HealthDay News) -- A therapeutic vaccine to treat prostate cancer appears safe and may be effective, according to the results of an early trial. The vaccine could give hope ...

A vaccine to combat prostate cancer is to be tested after studies suggested it could halve the rate of development of the disease. Unlike the vaccines to combat the virus that causes cervical cancer, ...

A Comprehensive OverviewThe global Peptide Cancer Vaccine Market is valued at USD 1.2 Billion in 2025 and is projected to reach a value of USD 15.72 Billion by 2035 at a CAGR (Compound Annual Growth ...

Researchers at the University of Florida are moving closer to developing what they have described as a "universal" cancer vaccine, according to a study published in Nature Biomedical Engineering on ...

) today announced that the FDA's clinical hold on the GVAX Prostate Cancer Vaccine (GVAX Prostate) for the treatment of prostate cancer has been lifted by FDA. Manufacturing of new GVAX Prostate is ...

Philip M. Arlen, Mahsa Mohebtash, Ravi A. Madan and James L. Gulley, Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, 20892, USA ...